The Food and Drug Administration cited Wilber W. Su, M.D. in Phoenix for one violation during a Feb. 27 inspection related to Bioresearch Monitoring, FDA data indicates.
FDA records note that the citation was issued because: ‘An investigation was not conducted according to the signed agreement and investigational plan.’
The FDA regularly inspects sites nationwide to assess whether workplaces and their products meet FDA’s compliance standards designed to protect public health. Findings from these inspections are made publicly available.
According to its official site, the FDA is a federal agency charged with overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information for this story was sourced from the U.S. Food and Drug Administration. Original data is available here.
